reposable

Since receiving FDA approval, the MarginProbe system has successfully demonstrated a consistent and significant decrease in re-excisions in breast cancer lumpectomy procedures. The growing body of MarginProbe published evidence supports a reduced amount of rates ranging from 50-79%. Al., reported a reduction of positive margins after lumpectomy leading to a reduction in the quantity of…